(Stx) type 1 and 2 produced by E. coli O157:H7 (STEC) are highly responsible for clinical signs, including septic shock, often leading to fatal consequences (Angus & van der Poll, 2013; Burvenich, Van Merris, Mehrzad, Diez-Fraile, & Duchateau, 2003; Kolenda, Burdukiewicz, & Schierack, 2015; Nguyen & Sperandio, 2012) .
Although the main options to avoid neonatal calf diarrhea are management measures like hygiene and feeding with colostrum after calving, antibiotic treatment is necessary in case of infection clinical signs appearing. Neonatal calf diarrhea caused by E. coli infections remains worldwide one of the most common reason of morbidity and mortality in unweaned dairy calves leading to significant economic and productivity losses in the cattle industry (Meganck, Hoflack, Piepers, & Opsomer, 2015; Picco et al., 2015; Uetake, 2013) . According to the National Animal Health Monitoring System (NAHMS), 57% of unweaned calf mortality due to diarrhea in most cases occurred in calves less than 1 month old (Cho & Yoon, 2014; El-Seedy, Abed, Yanni, & Abd El-Rahman, 2016 ). Thus, because of diarrhea and septicemia which affect dairy and beef production, E. coli infections remain a substantial problem even in calves with adequate passive immunity (Gerros, Semrad, & Proctor, 1995; Kolenda et al., 2015) . Moreover, as the main natural reservoir of Shiga exotoxin-producing E. coli (STEC), cattle and other ruminants are sources of zoonotic infections in humans-approx. 75% of human disease outbreaks were linked to bovine-derived products or cattle directly (Nguyen & Sperandio, 2012) . Although virulent strains of E. coli O157:H7 are rarely harbored by pigs (Ferens & Hovde, 2011) , studies demonstrate that the Stx2e variant represents the major virulence factor responsible for the pig edema disease, which is characterized by hemorrhagic lesions, neurological disorders, and often fatal outcomes especially for weaned piglets (Baranzoni et al., 2016; Moxley, 2000; Muthing et al., 2012; Oanh, Nguyen, De Greve, & Goddeeris, 2012) .
Antibiotic treatments of E. coli infections are sometimes controversial as they are believed to induce bacterial cell lysis and release of stored toxins. Additionally, some antimicrobials have also been reported to enhance toxin synthesis and production (Rahal, Fadlallah, Nassar, Kazzi, & Matar, 2015) . Therefore, an optimal approach for the treatment of E. coli infection should include not only eradication of bacteria but also a significant decrease in the Stx and LPS concentrations and/or neutralization of their toxic effects in blood and intestine of affected animals.
However, in contrast to clinical studies assessing the efficacy of commercially available antibiotics and to in vitro studies evaluating the susceptibility of bacteria to antibiotics, the direct effect on E. coli toxins is very occasionally documented and compared between antibiotics. The most complete recently published work about the effects of colistin on both Stx and endotoxin does not include comparison to other antibiotics (Percivalle, Monzillo, Pauletto, Marone, & Imberti, 2016) . Other authors compared the effect of several antimicrobials on the production and release of Stx by enterotoxemic E. coli isolates from pigs; however, they did not examine endotoxin (Uemura, Sueyoshi, Taura, & Nagatomo, 2004 ). Due to the consequences of E. coli infections in both animals and humans manifesting with strong clinical signs such as blood diarrhea, high fever, apart of direct bacteria effect inhibiting of activity of endotoxin and Shiga exotoxin seems to be antibiotic treatment choice.
Therefore, the aim of this study was to compare the in vitro activity of common bactericidal antibiotics to inhibition of LPS-and Stx-mediated cytotoxicity: colistin (CST), amoxicillin (AMX) (separately used or in combination), enrofloxacin (ENR), and ciprofloxacin (CIP). These antibiotics (except ciprofloxacin, which is an active metabolite of enrofloxacin) are used as commercially available preparations licensed for the treatment of the alimentary tract and/ or septicemia caused by susceptible strains of E. coli in young livestock. Therefore, the treatment effects of infections with a potential risk of shigatoxemia or E. coli septicemia and developing septic shock in the case of massive release of LPS are worth to be evaluated. To realize the study goals, we determined (a) the direct effect of antibiotics on endotoxin, (b) the effect of antibiotic treatments on LPS-mediated cytotoxicity in an experiment mimicking "natural infection," (c) the inhibiting effect of antibiotics on Stx2e-mediated cytotoxicity.
| MATERIAL SANDME THODS

| Antibiotics
As recommended by the manufacturers, the stock solutions of antibiotics were prepared in deionized water (CST, AMX, and CIP) or in DMSO (ENR) and then filtrated through 0.22-μm pore-size membrane filters (Millex GV filter, Millipore). All antibiotics were used individually, and in some experiments, AMX and CST were combined to investigate their synergistic effects on bacterial toxins. The expected maximum serum concentrations (C max ) of amoxicillin and colistin in calves were estimated to range from 650 to 1,600 ng/ml for CST and from 1,900 to 6,200 ng/ml for AMX (according to an internal pharmacokinetic study of an injectable suspension combining both antibiotics at the dose regimen of 10 mg amoxicillin/kg/day and 25,000 IU colistin/kg/day once per day for 3 days via the intramuscular route (Potencil ® ; Virbac, authorized for sale and treatment in EU countries.). As reported in the scientific literature (McKellar, Gibson, Monteiro, & Bregante, 1999) , pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after subcutaneous administration of ENR in cattle depends on antibiotic dosage. After treatment with injectable solution of enrofloxacin, the plasma C max in respect to ENR dose (2.5-12.5 mg/kg) can be estimated as 0.2 ± 0.084 to 0.7 ±0.23 μg/ml for ENR and 0.13 ±0.029 to 0.45 ±0.07 μg/ml for CIP. Therefore, three concentrations of each antibiotic were extrapolated (the lowest, medium, and the highest) and tested in the in vitro assays: 1,900, 4,050, and 6,200 ng/ml for AMX, 650, 1,125, and 1,600 ng/ml for CST, 0.2, 0.45, and 0.7 μg/ml for ENR, and 0.13, 0.29, and 0.45 μg/ml for CIP. When the AMX/CST association was used, the highest, medium, and lowest concentrations of each antibiotic were combined as follows: 6,200 ng/ml AMX plus 1,600 ng/ml CST (AMX/CST1), 4,050 ng/ml AMX plus 1,125 ng/ml CST (AMX/ CST2), and 1,900 mg/ml AMX plus 650 ng/ml CST (AMX/CST3). All chemicals needed were purchased from Sigma-Aldrich (Steinheim, Germany).
| Cellcultures
The A549 cell line (human epithelial lung carcinoma, ATCC ® CCL-185) sensitive to enteropathogenic E. coli strains (EPEC) and responding to EPEC LPS toxicity (Nishio et al., 2013) was used. Cells were cultured in Dulbecco's Modified Eagle Medium (DMEM) containing 10% heat-inactivated fetal bovine serum (FBS), 100 U/ml of penicillin, and 100 μg/ml of streptomycin in humidified atmosphere with 5% of CO 2 at 37°C (Heracell CO 2 Incubator).
The Vero cell line (Cercopithecus aethiops normal kidney cells, ATCC ® CRL-1586) with cells bearing Gb3 (glycolipid globotriaosyl ceramide) and Gb4 (globotetraosyl ceramide) receptors is susceptible to all Stx variants (Mainil, 1999) . Thus, this cell line was used to determine the ability of antibiotics to neutralize Stx2e-mediated cytotoxicity. Cells were cultured in Eagle MEM containing 10% heatinactivated FBS, 100 U/ml of penicillin, and 100 μg/ml of streptomycin in humidified atmosphere with 5% of CO 2 at 37°C (Heracell CO 2 Incubator). Both cell lines were purchased directly from the American Type Culture Collection (Rockville, MD, USA). Culture media, FBS, and antibiotics were purchased from Sigma-Aldrich (St.
Louis, MO, USA).
Cells at a density of 3 × 10 4 cells/ml (A549 cell line) or 2 × 10 5 cells/ml (Vero cell line) were seeded into 96-well plates (100 μl/well) (Nunc, Roskilde, Denmark) and cultured in standard medium with addition of 10% FBS for 24 hr. Next, the medium was replaced with a fresh one with 2% FBS and different concentrations of the tested antibiotics and/or toxin depending on the study design. The treated cells were then maintained in a humidified CO 2 -incubator at 37°C for 24-96 hr until viability determination. Depending on the experimental designs, controls included nontreated cells in standard medium or cells cultured in medium with addition of 1% DMSO or 1% Triton X-100.
| Bacterialendotoxin
Commercially available E. coli LPS was used (E. coli 0111:B4;
Sigma-Aldrich). Considering relatively low sensitivity of A549 cells to LPS, and following scientific papers (Liberati, Trammell, Randle, Barrett, & Toth, 2013; Nishio et al., 2013) , we used high (nonpharmacological) concentrations of LPS to detect its cytotoxic effect; to elicit the proper toxin concentration to be applied in this study, A549 cells were treated with various concentrations of LPS (0.1-750 μg/ml) for 24-72 hr. Based on MTT and lactate dehydrogenase (LDH) assays results (Supporting information   Table S1 ), LPS at a concentration of 500 μg/ml (high toxicity) and 250 μg/ml (close to 50% cytotoxic dose values, CD 50 ) was chosen for further determination of the potential antitoxic effect of the antibiotics.
| Bacterialstrainandprocessfor Stx2e production
According to recent epidemiological data, swine may carry Stx2e-producing E. coli with virulence gene profiles associated with human infections (Baranzoni et al., 2016; Muthing et al., 2012) . Moreover both colistin and amoxicillin were used before against E. coli -produced Stx2e (Konstantinova et al., 2008) . Therefore, in this part of the study, the O139 ETEEC reference strain (E. coli ATCC 23546), which releases Stx2e, was used. Harvesting of supernatant Stx2e-rich toxin was carried out according to Uemura et al. (2004) . The lyophilisate bacterial strain E. coli ATCC 23546 was suspended in brain heart infusion broth (BHI, Oxoid, UK) and incubated at 37°C overnight on a shaker 120 rpm. Next, the bacteria were screened on Columbia agar plates. The agar was supplemented with 5% of sheep blood to exclude potential contamination. The bacteria were then incubated in a thermostat overnight at 37°C (Memmert CO 2 incubator). Single colonies were picked from the plate, suspended in BHI broth (Oxoid), and incubated overnight at 37°C on a shaker 120 rpm.
The resulting bacterial culture was brought to a density of 10 To assess Stx2e-rich supernatant, we exactly followed Uemura procedure (Uemura et al., 2004) , however, we realized that this supernatant likely contains also endotoxin. Therefore, the content of collected Stx2e-rich supernatant reflects the presence of toxins during the infection process as was also carried out in many other studies with different bacterial exotoxin production (Aulik, Hellenbrand, Klos, & Czuprynski, 2010) .
| Determinationofcellviability
The cell viability was determined based on the mitochondrial activity and integrity of cell membranes using the yellow tetrazolium salt 3-(4,5 dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay and the LDH release assay, respectively.
The MTT colorimetric assay (Mosmann, 1983) was conducted as described elsewhere (Pachuta-Stec & Szuster-Ciesielska, 2015) .
Briefly, an MTT solution (25 μl of 5 mg/ml in PBS; Sigma-Aldrich) was added to each well containing cultured cells. The cells were incubated at 37 °C for 3 hr, and 100 μl of 10% SDS in 0. The LDH assay is based on the release of intracellular LDH through an injured cytoplasmic membrane. Therefore, detection of LDH in culture supernatants reflects the degree of cell membrane disruption (Nishio et al., 2013) . The LDH assay was performed according to the protocol outlined by the manufacturer of the Cytotoxic Detection Kit (Sigma-Aldrich) using 50 μl of each culture supernatant. Maximum LDH release was determined by the incubation of cells in standard medium containing 1% of Triton X-100 (positive control). The spectrophotometric absorbance was measured at 570-nm wavelength using a VICTOR X4 Multilabel Plate Reader (Perkin Elmer). Data were presented as % of the maximum LDH release after subtraction of the background determined from the medium alone (mean ± SD of three independent experiments, each with four replicates) calculated according to the following formula:
| Experimentaldesign
This experiment consisted of three parts; the first two parts referred to E. coli LPS, and the third one to E. coli Stx2e toxin. Experiments were preceded by preliminary studies to confirm the absence of a cytotoxic effect of the elicited concentrations of antibiotics in A549 cell cultures. In all designed experiments, we used culture media with no standard antibiotics addition (penicillin and streptomycin).
Preliminary studies as well as experiments were independently performed for three times. 6,200 ng/ml AMX plus 1,600 ng/ml CST (AMX/CST1), 4,050 ng/ml AMX plus 1,125 ng/ml COL (AMX/CST2), and 1,900 mg/ml AMX plus 650 ng/ml CST (AMX/CST3). Then, after the desired incubation time, the MTT and LDH tests were performed. Appropriate control cells were included as follows: nontreated cells and those cultured in medium with 1% DMSO or with 1% Triton X-100.
| Preliminarystudiesdesign
| Evaluationofthedirecteffectofantibioticson LPS(beforecontactwithcells)
To check any potential interaction between the antibiotics and LPS, each tested antibiotic, separately or in combination of AMX/CST in 2% DMEM (at final concentrations indicated in preliminary studies), was first incubated with 250 or 500 μg/ml LPS at 37°C for 1 hr. Then, the appropriate mixtures were added to A549 cell cultures for 24, 48, and 72 hr. The potential ability of the antibiotics to inhibition of activity of LPS reflected by increasing cell viability in comparison with cells treated only with LPS was evaluated using both MTT and LDH assays.
| Evaluationoftheantibioticeffectafter preincubationofA549cellswithLPS-"infectionand treatment"mimickingstudies
To mimic the real conditions of bacterial infection and treatment, the cell cultures were pretreated with 250 or 500 μg/ml LPS for 6, 12, or 24 hr (possible duration of disease development followed by diagnosis and treatment of E. coli infected animals). After the appropriate incubation time, the tested antibiotics at final concentrations indicated before were added during three consecutive days. Twentyfour hours after the last antibiotic treatment, the MTT and LDH tests were performed to assess the antibiotic ability to decrease LPS toxic effect and improve cell viability (Supporting information Figure S1 ).
| Evaluationoftheantibioticeffecton bacterial Stx2e
The aim of this part of study was to determine the ability of the tested antibiotics (in concentrations indicated before) to decrease Stx2e-mediated cytotoxicity. Following 4 hr of incubation with antibiotics, bacteria cultures (E. coli ATCC 23546) were sonicated, filtrated, then twofold (1:2-1:2,048) diluted in 2% MEM and incubated with Vero cells for 72 hr. Next, the MTT and LDH tests were performed. We calculated CD 50 (cytotoxic dose) value that reflected the toxin concentration giving 50% of its maximal cytotoxic effect. A higher value of CD 50 means increased toxic potential as higher dilution should be performed to achieve a 50% effect. By analyzing the differences between cell viability when treated with bacterial supernatants taken at the start point (control 0) and after 4 hr, we concluded that a 4-hr duration of incubation was sufficient to produce a high level of Stx2e toxin (see Results section).
| Statisticalanalysis
Normally distributed continuous variables were expressed as mean ± SD of at least four independent experiments, each with 84.3 ± 6.0* 80.6 ± 1.8* 1,125 ng/ml 52.1 ± 1.2* 39.2 ± 1.9* 17.3 ± 1.9
95.9 ± 1.7* 82.8 ± 3.6* 82.7 ± 2.3* 46.3 ± 2.6* 15.2 ± 1.4
6.4 ± 0.5 84.5 ± 1.7
86.5 ± 2.5* 77.8 ± 1.5* 650 ng/ml 43.2 ± 0.7* 30.5 ± 2.5* 16.4 ± 1.7
96.7 ± 1.3* 88.1 ± 1.3* 89.1 ± 2.5* 30.9 ± 3.6* 11.9 ± 2. Notes. *Statistically significant in comparison with the LPS control, p ≤ 0.05 (one-way ANOVA).
four or eight replicates. 
| RE SULTS
| Preliminarystudies-cytotoxicityofantibiotics in cell culture
The results of the MTT tests confirmed the lack of the toxicity of chosen concentrations of antibiotics used separately or in combination (AMX/CST) even during long-term contact with A549 cellscell viability was generally over 90% (Supporting information 
| Evaluationofthedirecteffectofantibioticson LPS(beforecontactwithcells)
Even if none of the tested antibiotics completely neutralized the highest LPS concentration, colistin was found to be the most effective. Except for the longest time of incubation, the viability of A549 cells significantly increased by 25%-40% (depending on the CST concentration) in comparison with LPS treatment only. Amoxicillin was also able to significantly inhibit the activity of high concentrations of LPS (500 μg/ml), however, with a slightly lower efficacy than colistin (Table 1) . When 250 μg/ml of LPS was used, both CST and AMX, regardless of their concentrations, almost completely neutralized the endotoxin. These differences, compared to the LPS control, were statistically significant. After 24 hr of incubation, cell viability was then comparable to that of the control cells and reached over 90%. Incubation prolonged to 72 hr only slightly decreased cell viability to over 80%. Enrofloxacin and ciprofloxacin were also able to neutralize LPS partially; however, this beneficial effect was significant only when the lower LPS concentration was used and only after 48 or 72 hr incubation (Table 1 ).
In comparison with CST and AMX used separately, incubation of LPS with the combination of these antibiotics caused more effective endotoxin neutralization, which was reflected by an additional increase in A549 cell viability. However, this effect strongly depended on the combined antibiotic concentration as well as on incubation time of such mixtures with the cells and was more visible when 500 μg/ml of LPS was used (Table 2) . Based on the best results achieved with 500 μg/ml LPS, below we compared the neutralizing effect of this high endotoxin concentration only. 31.9 ± 3.7
11.0 ± 2.0
Notes. p ≤ 0.05 (one-way ANOVA). AMX/CST1-6,200 ng/ml AMX plus 1,600 ng/ml CST. AMX/CST2-4,050 ng/ml AMX plus 1,125 ng/ml CST. AMX/CST3-1,900 ng/ml AMX plus 650 ng/ml CST. exhibited the best ability to additively neutralization of LPS exclusively at their highest concentration-this effect was visible even after 48 hr as well. At the lowest AMX/CST concentrations, the LPS neutralization effect was comparable to the activity of separate components (Figure 1 ). Considering the results achieved with enrofloxacin and ciprofloxacin, it was not surprising then that the AMX/CST combination exhibited significantly higher capability of endotoxin neutralization (Figure 2 ).
| Evaluationoftheantibioticeffectafter preincubationofA549cellswithLPS-"infectionand treatment"mimickingstudies
In this part of the study, we considered different durations of cell exposition to LPS (6-24 hr) before the antibiotic treatment, as well as various LPS and antibiotic concentrations. The threefold administration of enrofloxacin resulted in the accumulation of the cytotoxic effect due to DMSO presence (used as an ENR solvent). Therefore, we omitted here the results concerning ENR.
At the high LPS concentration (500 μg/ml), the most critical factor for cell viability was the time of exposure. After the shortest time of preincubation (6 hr) with LPS, the tested antibiotics showed a comparable, almost complete ability to decrease the toxic endotoxin effect, which was demonstrated by high cell viability. However, when the earlier contact of cells with LPS was extended to 12 hr, CIP lost this ability. The beneficial activity of AMX and CST depended on their concentration; the best protective effect was observed when the highest concentrations of these antibiotics were used. All the aforementioned results of the beneficial activity of the drugs were statistically significant (Table 3) .
After 24 hr of preincubation of cells with the high LPS concentration, only CST, among the tested antibiotics, partly protected cells against endotoxin toxicity. According to the MTT method, the viability of treated cells was still 20%, while cells incubated only with LPS lost their viability, and this difference was statistically significant (Table 3 ). In conclusion, the protection effect strongly depended on the delay of cell exposure to LPS (6-24 hr) before the antibiotic treatment.
F I G U R E 1
Comparison of LPS (500 μg/ml) neutralization between the amoxicillin and colistin combination (AMX/CST) and these antibiotics used separately. LPS and antibiotics were incubated together for 1 hr in 37°C before contact with A549 cells. Cytotoxicity was measured after 24, 48, or 72 hr incubation time. Results are presented as % of viable cells according to the MTT (a-c) and LDH (d-f) assays. Data are given as means ± SD with statistical significance (one-way ANOVA) AMX/CST1-6,200 ng/ml AMX plus 1,600 ng/ml CST AMX/CST2-4,050 ng/ml AMX plus 1,125 ng/ml CST AMX/CST3-1,900 mg/ml AMX plus 650 ng/ml CST According to the MTT method, both AMX and CST completely inhibited the cytotoxicity of lower LPS concentration (250 μg/ml), regardless of preincubation time (6-24 hr). A difference between these antibiotics appeared after LDH measurement; colistin was characterized by an activity around 20% higher than that of amoxicillin with a statistical significance in the case of the 6-12 hr cell preincubation with LPS. For CIP, also the longest cell preincubation period with LPS (250 μg/ml) was critical; its middle and lowest concentrations were revealed as significantly less beneficial for cell protection than in the case of AMX and CST (Table 3) . It should be underlined that the 3-day exposure of A549 cells to all the antibiotics applied individually, regardless of their concentration, did not change the high cell viability.
The AMX/CST combination exhibited better protecting potential than its components used separately, and this effect was visible especially after the longest preincubation period of LPS (500 μg/ml) with A549 cells. Depending on the type of assay (MTT or LDH), cell viability increased additionally by 10%-20%, and these differences were statistically significant (Table 4, Figure 3 ). 
| Evaluationoftheantibioticeffecton bacterial Stx2e
The toxicity (data not shown). Therefore, these dilutions of the bacterial supernatants were excluded from the presentation of the results.
All studied antibiotics were able to minimize Stx2e toxic effect.
However, their efficacy varied depending on drug concentrations (Tables 5 and 6 ). Considering the CD 50 values, the most effective antibiotics used individually were amoxicillin and ciprofloxacin (at their highest concentrations), which led to a decrease in the CD 50 value from over 1,400 (calculated for the bacterial control) to about 500 (according to both MTT and LDH assays) (Tables 5 and 6 
| D ISCUSS I ON
It has been established that the course of E. coli infection and induced clinical signs depends on the presence and activity of bacterial toxins such as LPS and Stx2e (Cornick, Matise, Samuel, Bosworth, & Moon, 2000; Dean-Nystrom, Bosworth, & Moon, 1997; Kolenda et al., 2015; Nguyen & Sperandio, 2012) . The clinical diarrhea treatment with colistin or amoxicillin in young calves caused by E. coli pathogenic strains has been often reported (Catry et al., 2016; Constable, 2004) . During antibacterial therapy, the concentration of these toxins may increase and lead to fatal complications due to bacterial membrane disruption and/or bactericidal activity (Hurley, 1995) .
The critical consequence of the activity of these toxins, particularly
Comparison of LPS (500 μg/ml) toxicity neutralization between the amoxicillin and colistin combination (AMX/CST), its components used separately (AMX and CST), and ciprofloxacin (CIP). A549 cells were preincubated with LPS (for 6, 12, or 24 hr) before the antibiotic treatment (during three consecutive days). Results are presented as % of viable cells according to the MTT (a-c) and LDH (d-f) assays. Data are given as means ± SD with statistical significance (one-way ANOVA) AMX/CST1-6,200 ng/ml AMX plus 1,600 ng/ml CST AMX/CST2-4,050 ng/ml AMX plus 1,125 ng/ml CST AMX/CST3-1,900 mg/ml AMX plus 650 ng/ml CST LPS, is endotoxic shock that causes sudden death during the few first hours from the beginning of the antibiotic therapy (Hardie & Kruse-Elliott, 1990; Holzheimer, 2001) . Therefore, antibiotic treatment during the strong bacterial infection caused intensive clinical signs followed with toxemia in animals should be targeted at not only eradication of the bacterial infection, but also a decrease in Stx and LPS concentrations or neutralization of their effects in blood and intestine. Hence, for the first time, we evaluated and compared the cell protecting potential of three commonly used bactericidal antibiotics (and one active metabolite-CIP) at concentrations close to those achieved in the blood of treated animals against bacterial endo-and exotoxin. Considering different study designs, the main conclusion from this study is that the combination of both amoxicillin and colistin (used in concentrations achieved in calve plasma after Potencil ® administration) exhibited the best cell protecting potential against both LPS and Stx2e toxins. Although Stx2e is swine associated, the mechanism of its toxic activity is very similar to other toxins in the Stx toxin family. Therefore, we decided to use more safety for human toxin as the basis in our experiment.
The assessment of the antibiotic efficacy in in vitro studies was based on the significant increase in cell viability following their contact with bacterial LPS or Stx2e during different experimental scenarios. To determine cell viability, at least two methods should be chosen (Bopp & Lettieri, 2008) . The MTT and LDH assays are commonly used to assess cytotoxicity (Fotakis & Timbrell, 2006 ) and have already been described to be appropriate to evaluate the viability of A549 cells (Uboldi et al., 2009) . Generally, the results of both the MTT and LDH tests were comparable. Some differences resulted from the sensitivity of the LDH and MTT methods, as LDH can be released outside cells upon damage of the plasma membrane earlier than mitochondrial disruption (Weyermann, Lochmann, & Zimmer, 2005) . Additionally, some papers reported that nonspecific intracellular reduction of tetrazolium can appear, which may lead to underestimated results of cytotoxicity by the MTT method (Jo et al., 2015) .
In the presented experimental conditions reflecting high endotoxemia (500 μg/ml of LPS) and in comparison with individual used antibiotics, the AMX/CST mixture had the highest additive effi- Notes. Data are given as means ± SD. AMX/CST1-6,200 ng/ml AMX plus 1,600 ng/ml CST. AMX/CST2-4,050 ng/ml AMX plus 1,125 ng/ml CST. AMX/CST3-1,900 ng/ml AMX plus 650 ng/ml CST. Notes. Data are given as means ± SD. AMX/CST1-6,200 ng/ml AMX plus 1,600 ng/ml CST. AMX/CST2-4,050 ng/ml AMX plus 1,125 ng/ml CST. AMX/CST3-1,900 ng/ml AMX plus 650 ng/ml CST.
Statistically significant in comparison with the bacterial control (4 hr), *p ≤ 0.01, **p ≤ 0.001, ***p ≤ 0.0001 (Student t test). Statistical differences among the antibiotics are depicted in Figure 6 .
Under field conditions, animal treatment is usually delayed by at Binding of cationic polypeptide CST to negatively charged lipid A (the toxic component of LPS) has been well documented before in in vitro studies (Morrison & Jacobs, 1976; Rhouma, Beaudry, Theriault, & Letellier, 2016; Warren, Kania, & Siber, 1985) , with following inhibition of inflammatory cytokine release, especially TNF-α. Moreover, the endotoxin-neutralizing activity of CST has been confirmed by in vivo challenge trials (Dosogne et al., 2002; Giacometti et al., 2003) and in veterinary clinical studies concerning cases with naturally occurring septic shock (Senturk, 2005) .
Those experiments also demonstrated the ability of CST to alleviate the clinical implications of endotoxemia and even to protect against lethality in a rat model (Giacometti et al., 2003; Senturk, 2005 AMX/CST1-6,200 ng/ml AMX plus 1,600 ng/ml CST AMX/CST2-4,050 ng/ml AMX plus 1,125 ng/ml CST AMX/CST3-1,900 mg/ml AMX plus 650 ng/ml CST that study, the endotoxin was not neutralized (Melhus, 2001 ). On the other hand, other β-lactams, cefaclor, and cefpodoxime decreased synthesis of IL-6 and TNF-α in human granulocytes phagocytizing E. coli (Scheffer & Konig, 1993) .
Thus, even inferior to colistin, the endotoxin-neutralizing activity of amoxicillin demonstrated in the present study is very original, not only as individually used antibiotic but especially in combination with colistin, where an additive beneficial effect was observed. Similar additive effect was observed by Ghiselli et al. (2002) who indicated that the combination of amoxicillin-clavulanate in experimental rats model influenced on LPS activity. However, further investigations are needed to explain the nature of such interactions.
A challenge study with E. coli mastitis in cattle revealed that enrofloxacin treatment significantly limited bacteria in milk but did not reduce LPS concentration in animal plasma (Dosogne et al., 2002) . This fact could suggest that enrofloxacin is unable to neutralize endotoxin. Indeed, further research clearly indicated a lack of physicochemical interactions between fluoroquinolones and LPS (Lindner, Wiese, Brandenburg, Seydel, & Dalhoff, 2002) .
In our experiments, we decided also to include ciprofloxacin as model substance, because it is a major metabolite of enrofloxacin.
In fact, in treated cattle, about 35% of enrofloxacin is metabolized to ciprofloxacin. Although ciprofloxacin is dedicated for humans, in EU countries, it is registered also for treatment of calves of less than 1 year of age (The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2015, https://www.efsa.europa.eu).
Ciprofloxacin is probably able to at least partly neutralize of LPS as THP-1 mononuclear cells released less TNF after exposure to filtrates of E. coli cultures treated with this antibiotic, however, the nature of such interaction was not described (Simon, Koenig, & Trenholme, 1991 AMX/CST1-6,200 ng/ml AMX plus 1,600 ng/ml CST AMX/CST2-4,050 ng/ml AMX plus 1,125 ng/ml CST AMX/CST3-1,900 mg/ml AMX plus 650 ng/ml CST In the present study mimicking natural infection and treatment, when the low concentration of LPS was used, ciprofloxacin protected cells against LPS-mediated cytotoxicity comparably to amoxicillin and colistin. The differences among these antibiotics appeared in the case of the high LPS concentration-in contrast to AMX and CST, ciprofloxacin was efficient exclusively after the shortest contact of the cells with endotoxin. Such an effect of CIP was probably caused by limiting proinflammatory cytokine production as other in vitro and in vivo experiments supported that ciprofloxacin at a pharmacological concentration above 25 pg/ml significantly inhibited production of IL-1α, IL-1β, IL-6, and TNF-α in human monocytes after stimulation with LPS (Bailly, Fay, Ferrua, & Gougerot-Pocidalo, 1991) .
Additionally, recent studies described the immunomodulatory activity of another fluoroquinolone used in humans-moxifloxacin -as a beneficial regulator of the expression of TLRs and proinflammatory cytokines in response to LPS (Bode et al., 2014) . Weiss et al.
reported that those anti-inflammatory properties of moxifloxacin, including the reduction of the proinflammatory cytokines IL-1β and IL-6, could be explained through its inhibitory effect on the TLR4/ LPS-signaling pathway (Weiss et al., 2004) . However, in vivo effects of antibiotics on LPS-induced cytokine production could be more complex as in some aspects, it differed from in vitro reported results (Bailly et al., 1991) . Interaction of colistin and Stx toxin was already documented last year by Percivalle et al. (2016) , who described the ability of this drug to inhibit E. coli 0157:H7 Shiga-like toxin release, as well as binding thereof, thereby protecting Vero cells. Similarly to LPS, there is no information in scientific papers about the Stx-neutralizing activity of amoxicillin or other penicillins. Although the ability of enrofloxacin to reduce production and release of Stx by enterotoxaemic ETEC is well known (Uemura et al., 2004) , its neutralizing potential on Shiga toxins has not been described. However, another fluoroquinolone, ciprofloxacin, exhibited an ability to either increase or decrease Stx production, depending on its concentration (McGannon, Fuller, & Weiss, 2010) . Subinhibitory concentrations of the antibiotic increased Stx expression, while no Stx was detected at a concentration at or above MIC (minimal inhibitory concentration). In the present experiment, ciprofloxacin was used at concentrations above MIC, which is determined for E. coli as 0.12 μg/ml (Baudry-Simner, Singh, Karlowsky, Hoban, & Zhanel, 2012) .
To sum up, the main observation of this study is the significant beneficial in vitro effects demonstrated by colistin and amoxicillin (especially used in combination of concentrations found during 
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